• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及丙型肝炎病毒的流行病学及医源性传播:一种贝叶斯合并方法

The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach.

作者信息

Pybus O G, Drummond A J, Nakano T, Robertson B H, Rambaut A

机构信息

Department of Zoology, University of Oxford, Oxford, United Kingdom.

出版信息

Mol Biol Evol. 2003 Mar;20(3):381-7. doi: 10.1093/molbev/msg043.

DOI:10.1093/molbev/msg043
PMID:12644558
Abstract

Hepatitis C virus (HCV) is a leading cause of liver cancer and cirrhosis, and Egypt has possibly the highest HCV prevalence worldwide. In this article we use a newly developed Bayesian inference framework to estimate the transmission dynamics of HCV in Egypt from sampled viral gene sequences, and to predict the public health impact of the virus. Our results indicate that the effective number of HCV infections in Egypt underwent rapid exponential growth between 1930 and 1955. The timing and speed of this spread provides quantitative genetic evidence that the Egyptian HCV epidemic was initiated and propagated by extensive antischistosomiasis injection campaigns. Although our results show that HCV transmission has since decreased, we conclude that HCV is likely to remain prevalent in Egypt for several decades. Our combined population genetic and epidemiological analysis provides detailed estimates of historical changes in Egyptian HCV prevalence. Because our results are consistent with a demographic scenario specified a priori, they also provide an objective test of inference methods based on the coalescent process.

摘要

丙型肝炎病毒(HCV)是导致肝癌和肝硬化的主要原因,埃及可能是全球丙型肝炎病毒感染率最高的国家。在本文中,我们使用一种新开发的贝叶斯推理框架,从采样的病毒基因序列估计埃及丙型肝炎病毒的传播动态,并预测该病毒对公共卫生的影响。我们的结果表明,埃及丙型肝炎病毒感染的有效数量在1930年至1955年间经历了快速指数增长。这种传播的时间和速度提供了定量的遗传证据,表明埃及丙型肝炎病毒疫情是由广泛的抗血吸虫病注射运动引发和传播的。尽管我们的结果表明此后丙型肝炎病毒传播有所下降,但我们得出结论,丙型肝炎病毒可能会在埃及持续流行数十年。我们结合群体遗传学和流行病学分析,对埃及丙型肝炎病毒感染率的历史变化进行了详细估计。由于我们的结果与先验指定的人口统计学情景一致,它们也为基于合并过程的推理方法提供了客观检验。

相似文献

1
The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach.埃及丙型肝炎病毒的流行病学及医源性传播:一种贝叶斯合并方法
Mol Biol Evol. 2003 Mar;20(3):381-7. doi: 10.1093/molbev/msg043.
2
Exponential spread of hepatitis C virus genotype 4a in Egypt.丙型肝炎病毒4a基因型在埃及的指数式传播。
J Mol Evol. 2004 Feb;58(2):191-5. doi: 10.1007/s00239-003-2541-3.
3
Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV).出生-死亡天际线图揭示了 HIV 和丙型肝炎病毒 (HCV) 流行传播的时间变化。
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):228-33. doi: 10.1073/pnas.1207965110. Epub 2012 Dec 17.
4
[Hepatitis C in Egypt, a iatrogenic epidemy].[埃及的丙型肝炎,一场医源性流行病]
Ned Tijdschr Geneeskd. 2000 Oct 14;144(42):2024-5.
5
Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications.埃及丙型肝炎病毒感染的空间流行病学:分析与启示
Hepatology. 2014 Oct;60(4):1150-9. doi: 10.1002/hep.27248. Epub 2014 Aug 19.
6
Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.埃及 2001-2012 年丙型肝炎病毒感染预防和控制进展。
MMWR Morb Mortal Wkly Rep. 2012 Jul 27;61(29):545-9.
7
Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt.埃及丙型肝炎病毒持续地方性传播的证据。
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14757-62. doi: 10.1073/pnas.1008877107. Epub 2010 Aug 9.
8
The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960.喀麦隆的丙型肝炎病毒流行:1920年至1960年间快速传播的遗传学证据。
Infect Genet Evol. 2007 Jun;7(3):361-7. doi: 10.1016/j.meegid.2006.10.003. Epub 2006 Nov 29.
9
Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.预防和治疗干预对埃及丙型肝炎病毒传播的影响(ANRS 1211):一项建模研究。
Lancet Glob Health. 2014 Sep;2(9):e541-e549. doi: 10.1016/S2214-109X(14)70188-3. Epub 2014 Aug 27.
10
Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.丙型肝炎病毒传入苏格兰及其后续区域传播的时空重建
J Virol. 2015 Nov;89(22):11223-32. doi: 10.1128/JVI.02106-15. Epub 2015 Aug 26.

引用本文的文献

1
Historical drivers of HCV Subtypes 1b and 3a in Thailand and 6f in Phetchabun, an HCV endemic area of the country.泰国丙型肝炎病毒1b型和3a型以及碧差汶(该国丙型肝炎流行地区)6f型的历史驱动因素。
Virus Evol. 2024 Sep 11;10(1):veae079. doi: 10.1093/ve/veae079. eCollection 2024.
2
Variational Supertrees for Bayesian Phylogenetics.变分超级树在贝叶斯系统发生学中的应用。
Bull Math Biol. 2024 Aug 5;86(9):114. doi: 10.1007/s11538-024-01338-5.
3
Epidemiological inference from pathogen genomes: A review of phylodynamic models and applications.
基于病原体基因组的流行病学推断:系统发育动力学模型及其应用综述
Virus Evol. 2022 Jun 2;8(1):veac045. doi: 10.1093/ve/veac045. eCollection 2022.
4
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.在纽约检测和描述 SARS-CoV-2 谱系 B.1.526。
Nat Commun. 2021 Aug 9;12(1):4886. doi: 10.1038/s41467-021-25168-4.
5
Are Skyline Plot-Based Demographic Estimates Overly Dependent on Smoothing Prior Assumptions?基于天际线图的人口估计是否过度依赖于平滑先验假设?
Syst Biol. 2021 Dec 16;71(1):121-138. doi: 10.1093/sysbio/syab037.
6
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.纽约SARS-CoV-2谱系B.1.526的检测与特征分析。
bioRxiv. 2021 Apr 22:2021.02.14.431043. doi: 10.1101/2021.02.14.431043.
7
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa.在英国感染非洲流行的丙型肝炎病毒基因型/亚型的患者中,直接作用抗病毒治疗和再治疗的真实世界结局。
J Infect Dis. 2022 Sep 21;226(6):995-1004. doi: 10.1093/infdis/jiab110.
8
Adaptive Metropolis-coupled MCMC for BEAST 2.适用于BEAST 2的自适应 metropolis耦合马尔可夫链蒙特卡罗方法
PeerJ. 2020 Sep 16;8:e9473. doi: 10.7717/peerj.9473. eCollection 2020.
9
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.西班牙丙型肝炎病毒 NS5A 特异性直接作用药物的流行病史和基线耐药情况。
Sci Rep. 2020 Aug 3;10(1):13024. doi: 10.1038/s41598-020-69692-7.
10
Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt.描述埃及丙型肝炎病毒传播中肠外驱虫治疗的历史作用。
Int J Epidemiol. 2020 Jun 1;49(3):798-809. doi: 10.1093/ije/dyaa052.